Biologics 2023

Biologics 2023: Oxford Global’s 16th Annual Proteins & Antibodies Congress, 30 – 31 March 2023, London, UK will be attended by over 400 visionary leaders to network about the latest innovations in the field.  

With a revamped agenda, visionary leaders will be looking at novel computational approaches & tools, AI/ML utilisation as well as advanced engineering methods, bioanalysis and cell engagers.

Featuring a pre-event focus day on 29th March with the opening event keynote address on ‘Antibody Discovery & Engineering In A Chronic Disease Management Perspective; delivered by Erik Vernet, Director of Antibody Technology, Novo Nordisk.  

The event will be looking at the following main themes:  

• Day 1 Track 1: Antibody-Based Molecular Engineering 
• Day 1 Track 2: Emerging Techniques for Bioanalysis & Characterisation and Quality Control Systems 
• Day 2 Track 1 – Computational Tools, Structural Approaches & Automation in Engineering 
• Day 2 Track 2 – Multi Specific Antibodies, Cell Engagers & Other New Modalities 

Key Speakers Include:  

• Aneesh Karatt Vellatt, Chief Scientific Officer, Maxion Therapeutics 
• Annelise Vuidepot, Chief Technology Officer, Immunocore 
• Dan Snell, Vice President, Translational Sciences, Numab Therapeutics 
• Stefan Warmuth, Vice President, Protein Engineering & CMC, Numab Therapeutics 
• Colette Johnston, Vice President, Discovery, Crescendo Biologics 
• Amita Datta-Mannan, Associate Vice President, Eli Lilly & Company 
• Samuel Pine, Senior Director and Head of Bioanalysis and Immunogenicity, Sanofi 
• Maria Knudsen, Director, Salipro Biotech 
• Ryan Fiehler, Associate Director, Discovery, F-star Therapeutics 
• Stefan Grüner, Associate Director of Protein Engineering, Pieris Pharmaceuticals 

Featuring a series of dedicated interactive sessions:

• Panel Discussion: Different Technologies In Antibody Engineering  
• Panel Discussion: Immunogenicity Of New Modalities 
• Roundtable: Influence Of Biologics Physio-Chemical Properties On PK & Disposition  
• Roundtable: Bioassay Strategies For Biologics Identification 
• Workshop: Integration Of Data For AI/ML & Structural Modelling 
• Workshop: T Cell Engager Biology And Therapeutic Strategies  

Co-located with the Peptides & Oligonucleotides Congress. For more information contact marketing@oxfordglobal.co.uk.